drugset
drugset / Trial / NCT07027982

A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

NCT07027982 ↗

Phase 1 Completed 32 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelScreening

Summary

This study will evaluate the pharmacokinetics and safety of Diluted and Undiluted Intravenous DA-5217 in healthy adult subjects.

Timeline

Start
2025-07-16
Primary completion
2025-08-14
Completion
2025-08-14

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-5217 Unknown — Intravenous

Indications

No indication recorded.